Terms of Use
Acceptance of Terms
This website is owned and operated by PharmaEssentia USA. Your access to and use of the PharmaEssentia USA website (the “Site”) is subject to the following terms of use (these “Terms of Use”) and all applicable laws. By accessing, browsing and submitting information to the Site, you accept and agree to, without limitation or qualification, these Terms of Use, and you acknowledge that any other agreements between you and PharmaEssentia USA are superseded and have no force or effect with respect to your access and use of the Site.
Trademarks, Copyrights & Prohibited Transmissions
The contents of this Site, including trade names, logos, service marks, graphics, documents, videos, photographs, and other materials available on this site are protected under applicable copyright and trademark laws, and no content may be used except as provided in these Terms of Use without the written permission of PharmaEssentia USA. Any use of Site content that constitutes an infringement of the rights of PharmaEssentia USA or any third party (including, without limitation, defamation, infringement of privacy rights, or rights of publication) is strictly prohibited.
Further, you may not post or transmit any unlawful, threatening, libelous, defamatory, obscene, indecent, inflammatory, pornographic or profane material or any material that could constitute or encourage conduct that would be considered a criminal offense, give rise to civil liability or otherwise violate any law. You are also prohibited from posting or transmitting any information which contains a virus, bug or other harmful item or may be used to unlawfully collude against another person in restraint of trade or competition. You shall be solely liable for any damages resulting from any infringement of copyright, trademark, or other proprietary right, or any other harm resulting from your access to or use of the Site. PharmaEssentia USA will fully pursue enforcement of its intellectual property rights, to and including criminal prosecution, in the event of unauthorized use of Trademarks or other Site contents.
Medical and Product Information
The content available on this Site is intended for United States residents. However, this Site and links to other sites may contain information about products that may or may not be available in a particular country or region, and which may be approved by applicable competent authorities for sale or use with different indications and restrictions in different countries, and under different names and trademarks.
No information provided on this Site should be interpreted as a promotion or solicitation for products or services not authorized under the laws of the United States. Any information provided on this Site is based on United States labeling requirements and may not be appropriate outside of the United States.
This Site does not provide medical advice, and no information available on this Site should be relied upon as a replacement for advice provided by your physician or healthcare professional.
Exclusion of Warranty
PharmaEssentia USA takes reasonable steps to provide accurate and up-to-date information on this Site, but makes no warranties or representations as to the accuracy of the information available on this Site and assumes no liability or responsibility for any errors or omissions in the Site content. All Site content is provided to you AS IS, and to the extent allowed under applicable law, WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT.
Information You Provide
Any Personal Information contained in the content of any communications or submissions to this Site is governed by the Site’s Privacy Notice. Otherwise, the contents of any communications, submissions or other materials you send to PharmaEssentia USA by e-mail, posting, or transmission method, including questions, comments, information, suggestions, or other shall be deemed non-confidential and non-proprietary. You understand and agree that PharmaEssentia USA may use such contents for any purpose, including but not limited to, publication, broadcast, posting, disclosure, transmission, reproduction, etc. PharmaEssentia USA also reserves the rights to use, without limitation and without compensation to you, subject to applicable law, any ideas, concepts, know-how, techniques, etc., contained in any communication you send to PharmaEssentia USA for any purpose, including, but not limited to, developing, manufacturing, marketing and sale of products and services.
Links / Other Sites
PharmaEssentia USA does not endorse, nor is PharmaEssentia USA responsible for the content or operation of any third-party websites that may be linked to this Site. You are strongly encouraged to review the Terms and Conditions and Privacy Notices or Policy available on other websites.
Social Media
PharmaEssentia USA’s Corporate Social Media accounts are:
- PharmaEssentia USA LinkedIn: https://www.linkedin.com/company/PharmaEssentia USA-corporation/
Any other accounts are not officially recognized by PharmaEssentia USA, and PharmaEssentia USA employees’ social media accounts do not necessarily reflect or express PharmaEssentia USA’s official views or positions.
Applicable Law
These Terms of Use shall be governed by the laws of the state of Massachusetts. You consent and submit to the exclusive jurisdiction of the state and federal courts located in the state of Massachusetts, United States of America, in all questions or controversies arising out of your access to or use of this Site and these Terms of Use. To the extent allowed under applicable law, any claims or cause of action arising from or relating to your access or use of this Site must be brought within two (2) years from the date on which such claim or action arose or accrued.
Changes to these Terms and Removal of Site Content
PharmaEssentia USA may, at any time, and without prior notice, revise the Terms of Use governing access and use of this Site. PharmaEssentia USA also reserves the right to remove the Site or any content available on the Site, in part or entirely, without prior notice. All revisions to the Terms of Use will be posted on this Site. You acknowledge that you are bound by any such revisions and you are strongly encouraged to periodically review the Terms of Use pertaining to your access and use of this Site.
Forward-Looking Statements
This Site contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based on the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. Forward-looking statements may be indicated by the use of words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other terms of similar meaning appearing in discussions of future operating or financial performance. There can be no guarantees as to the receipt of necessary regulatory approvals of pipeline products or their commercial success. Actual results may differ significantly from those set forth in the forward-looking statements.
Risks and uncertainties may include but are not limited to the impact of general industry conditions and economic factors; pharmaceutical industry regulation and health care legislation in the United States and internationally; new products and patents of competitors; challenges inherent in new product development, exposure to litigation, including patent litigation, and/or regulatory actions and those identified in our filing with the Securities and Exchange Commission.
The information provided on this is believed to accurate and current at the time of original publication. PharmaEssentia USA assumes no obligation to update any of the forward-looking statements to conform them to actual results or to changes in our expectations, except as may be required by law.
Meredith Manning
General Manager, U.S.
Meredith Manning joined PharmaEssentia as General Manager for the U.S. in 2020, bringing with her more than 20 years of experience in global commercialization and brand building for biopharmaceuticals and medical devices. She was most recently Chief Commercial Officer at resTORbio™, and previously served as Vice President of Global Product Strategy in Hemophilia for Shire (formerly Baxalta) and Baxter. She previously held a series of marketing leadership roles at Vertex® and Pfizer.
Meredith received a B.S. at Colorado College and an MBA from the University of Chicago Booth School of Business.
Jack Hwang, Ph.D.
General Manager, Taiwan
Jack Hwang joined PharmaEssentia in 2006 and has served as General Manager in Taiwan since 2015. With training in organic chemistry, he has held a series of leadership roles at prior companies, including as Senior Director at Optimer Pharmaceuticals, Senior Group Leader at Array BioPharma®, and earlier as a research scientist at Amgen® and Ligand® Pharmaceuticals.
Jack completed his Ph.D. in organic chemistry and post-doctoral fellowship in natural product synthesis at the University of Pennsylvania.
Albert Qin, M.D. Ph.D.
Chief Medical Officer
Albert Qin, who joined PharmaEssentia in 2017, brings more than 20 years of experience in the biotech and pharmaceutical industry with an emphasis on clinical development. Recent leadership roles include Chief Medical Officer at China Health Group, Chief Scientific Officer and Corporate Officer at SymBio Pharmaceuticals, and Medical Director at ImmunoGen™. Earlier in his career, he held clinical development and R&D roles at Pfizer, Bayer and Biogen®. At Biogen, he did innovative research and made discoveries related to cytokines, immunology, and gene therapy.
Albert completed his medical degree in the Department of Medicine at Shandong Medical University in China and his Ph.D. in biochemistry and molecular pharmacology at Harvard Medical School. He completed a visiting research fellowship at Brigham and Women’s Hospital.
Ching-Leou Teng, Ph.D.
Chairperson of the Board of Directors
Ching-Leou Teng offers extensive pharmaceutical science and development expertise to the PharmaEssentia team. After joining the company as head of operations in 2003, she became Chairperson in 2009. Prior to PharmaEssentia, Ching-Leou held multiple leadership roles in drug delivery research and pharmaceutical development at Ionis™ (formerly ISIS) Pharmaceuticals, and previously served as a reviewer in the Pharmacokinetics Evaluation Branch of the Division of Biopharmaceutics at the Food and Drug Administration (FDA). Early in her career, Ching-Leou was a registered pharmacist at hospitals in Taiwan.
Ching-Leou completed her B.S. in pharmacy at Taipei Medical College, followed by an M.S. in pharmaceutical science at North Dakota State University. She completed her Ph.D. and post-doctoral fellowship at the University of Michigan.
Ko-Chung Lin, Ph.D.
Founder and Chief Executive Officer
Ko-Chung Lin has led PharmaEssentia since 2002, driven by rich and diverse career experiences at leading U.S. pharmaceutical companies. He is recognized for medicinal chemistry advances in pegylation, including the invention of pegylated-interferon, that have led to the development and successful entry of multiple leading therapeutics. Prior to PharmaEssentia, Ko-Chung was head of the Adentri® and pegylated-Avonex® programs at Biogen®. Earlier in his career, he contributed to inventions in HIV in his research roles at Monsanto.
Ko-Chung received B.S. and M.S. degrees in chemistry from National Taiwan Normal University, his Ph.D. from the University of Missouri, and completed a post-doctoral fellowship at the University of Michigan.